Hiroshi Saeki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hiroshi Saeki has a total of 350 co-authors. Here are the top co-authors by number of shared publications:
- Ken Shirabe
The Japanese Society of Gastroenterological Surgery Tokyo Japan
24 shared publications - Makoto Sakai
Division of Gastroenterological Surgery, Department of General Surgical Science, Graduate School of Medicine, Gunma University, Maebashi, Japan
18 shared publications Ken Shirabe
Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Japan
17 shared publications- Akihiko Sano
Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Japan
16 shared publications - Takehiko Yokobori
Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Japan
15 shared publications - Makoto Sohda
Department of General Surgical Science, Graduate School of Medicine, Gunma University, Maebashi, Japan
13 shared publications
Latest Publications
- 20 October 2026
- Published by Springer Nature in International Journal of Clinical Oncology
- p. 1-11
Safety and efficacy of neoadjuvant S-1 and oxaliplatin therapy for gastric cancer in the elderly: combined phase II trials of KSCC1601 and KSCC1801
Background The efficacy of neoadjuvant chemotherapy in elderly patients with locally advanced gastric cancer remains unclear. We evaluated neoadjuvant S-1 plus oxaliplatin (SOX) therapy in elderly patients using patient data from two phase II trials. Methods Patient data from KSCC1601 and KSCC1801 phase II trials were integrated. Patients were divided into an elderly group (age ≥75 years) and a non-elderly group (age p = 0.64; RFS: HR = 1.12, 95% CI 0.51–2.44, p = 0.79). Undifferentiated histology, stage III disease, and poor pathological response were associated with worse survival. Conclusions Neoadjuvant SOX therapy is feasible in selected elderly patients with locally advanced gastric cancer and yields survival comparable to those of younger patients.
- 20 October 2026
- Published by Springer Nature in International Journal of Clinical Oncology
- p. 1-11
Safety and efficacy of neoadjuvant S-1 and oxaliplatin therapy for gastric cancer in the elderly: combined phase II trials of KSCC1601 and KSCC1801
Background The efficacy of neoadjuvant chemotherapy in elderly patients with locally advanced gastric cancer remains unclear. We evaluated neoadjuvant S-1 plus oxaliplatin (SOX) therapy in elderly patients using patient data from two phase II trials. Methods Patient data from KSCC1601 and KSCC1801 phase II trials were integrated. Patients were divided into an elderly group (age ≥75 years) and a non-elderly group (age p = 0.64; RFS: HR = 1.12, 95% CI 0.51–2.44, p = 0.79). Undifferentiated histology, stage III disease, and poor pathological response were associated with worse survival. Conclusions Neoadjuvant SOX therapy is feasible in selected elderly patients with locally advanced gastric cancer and yields survival comparable to those of younger patients.
- 20 September 2026
- Published by Springer Nature in Esophagus
- Vol. 23 (4) , 733-742
Improved operative mortality after esophagectomy in patients aged ≥ 75 years over a decade: a nationwide Japanese retrospective cohort study
Background Esophagectomy is associated with substantial morbidity and mortality, particularly in older patients. Although minimally invasive surgery (MIS) has been widely adopted, its contribution to improve operative outcomes in this population remains unclear. This study aimed to evaluate temporal trends in short-term outcomes after esophagectomy in patients aged ≥ 75 years and determine whether the increasing adoption of MIS contributed to improved operative mortality. Methods Using the Japanese National Clinical Database, we analyzed patients aged ≥ 75 years who underwent radical esophagectomy for esophageal cancer between 2014 and 2024. The primary and secondary endpoints were operative mortality and severe postoperative complications (Clavien–Dindo grade ≥IIIa), respectively. Multivariable logistic regression analyses were performed, including sensitivity analyses additionally adjusted for MIS. Results Among 7,678 patients, patient complexity increased over time, with higher proportions of octogenarians, patients with American Society of Anesthesiologists Physical Status ≥ 3, and patients receiving preoperative chemotherapy. Open thoracotomy decreased from 53.1% to 6.5%, whereas robot-assisted esophagectomy increased from 0% to 34.8%. Operative mortality decreased from 4.7% to 2.4%, with a risk-adjusted odds ratio (OR) of 0.49 (95% confidence interval [CI] 0.35–0.67; P < 0.001). Risk of severe postoperative complications remained unchanged (adjusted OR = 1.12, 95% CI 0.98–1.29; P = 0.11). Mortality reduction remained significant after adjustment for MIS (OR = 0.58, 95% CI 0.41–0.83; P = 0.003). Conclusions Despite increasing patient complexity, operative mortality after esophagectomy in older patients improved substantially over the past decade. This improvement was unlikely to be explained by the increasing use of MIS alone and may reflect broader advances in perioperative management and other system-level factors. These findings have important implications for surgical care in aging populations worldwide.
- 20 September 2026
- Published by Springer Nature in Esophagus
- Vol. 23 (4) , 733-742
Improved operative mortality after esophagectomy in patients aged ≥ 75 years over a decade: a nationwide Japanese retrospective cohort study
Background Esophagectomy is associated with substantial morbidity and mortality, particularly in older patients. Although minimally invasive surgery (MIS) has been widely adopted, its contribution to improve operative outcomes in this population remains unclear. This study aimed to evaluate temporal trends in short-term outcomes after esophagectomy in patients aged ≥ 75 years and determine whether the increasing adoption of MIS contributed to improved operative mortality. Methods Using the Japanese National Clinical Database, we analyzed patients aged ≥ 75 years who underwent radical esophagectomy for esophageal cancer between 2014 and 2024. The primary and secondary endpoints were operative mortality and severe postoperative complications (Clavien–Dindo grade ≥IIIa), respectively. Multivariable logistic regression analyses were performed, including sensitivity analyses additionally adjusted for MIS. Results Among 7,678 patients, patient complexity increased over time, with higher proportions of octogenarians, patients with American Society of Anesthesiologists Physical Status ≥ 3, and patients receiving preoperative chemotherapy. Open thoracotomy decreased from 53.1% to 6.5%, whereas robot-assisted esophagectomy increased from 0% to 34.8%. Operative mortality decreased from 4.7% to 2.4%, with a risk-adjusted odds ratio (OR) of 0.49 (95% confidence interval [CI] 0.35–0.67; P < 0.001). Risk of severe postoperative complications remained unchanged (adjusted OR = 1.12, 95% CI 0.98–1.29; P = 0.11). Mortality reduction remained significant after adjustment for MIS (OR = 0.58, 95% CI 0.41–0.83; P = 0.003). Conclusions Despite increasing patient complexity, operative mortality after esophagectomy in older patients improved substantially over the past decade. This improvement was unlikely to be explained by the increasing use of MIS alone and may reflect broader advances in perioperative management and other system-level factors. These findings have important implications for surgical care in aging populations worldwide.
- 17 July 2026
- Published by Springer Nature in British Journal of Cancer
- Vol. 135 (8) , 1328-1341
High KPNA2 expression predicts poor prognosis in pathological T4 colorectal cancer by importing c-Myc into the nucleus to suppress p53-dependent p21 expression
Background Advanced colorectal cancer (CRC) is an aggressive subtype with a poor prognosis, highlighting the need for effective biomarkers. Karyopherin alpha 2 (KPNA2), a nuclear transport protein, facilitates the expression of oncogenic transcription factors (e.g. c-Myc). However, the clinical and functional implications of KPNA2 expression in pathological T4 (pT4) CRC in relation to the status of p53, a tumour suppressor, and c-Myc regulation remain unclear. Methods KPNA2 and p53 expression in 78 surgically resected pT4 CRC samples was assessed using immunohistochemistry. Functional analyses were conducted using short hairpin RNA-mediated KPNA2 knockdown in p53-mutant, wild-type p53 and p53-null CRC cell lines. Results High KPNA2 expression significantly associated with aggressive tumour characteristics and poor prognosis, particularly in the wild-type p53 patient subgroup. Clinically, elevated KPNA2 levels correlated with increased distant metastasis rates and reduced disease-free survival, especially in patients with wild-type p53 receiving adjuvant chemotherapy. KPNA2 suppression reduced cell proliferation, inhibited xenograft tumour growth and selectively enhanced 5-FU and oxaliplatin sensitivity in wild-type p53 CRC cells. KPNA2 knockdown impaired nuclear c-Myc transport and induced p53-dependent p21 expression; however, these effects were not observed in p53-mutant or p53-null CRC. Conclusions KPNA2 expression may serve as an important prognostic biomarker and therapeutic target in patients with locally advanced wild-type p53 CRC.
- 17 July 2026
- Published by Springer Nature in British Journal of Cancer
- Vol. 135 (8) , 1328-1341
High KPNA2 expression predicts poor prognosis in pathological T4 colorectal cancer by importing c-Myc into the nucleus to suppress p53-dependent p21 expression
Background Advanced colorectal cancer (CRC) is an aggressive subtype with a poor prognosis, highlighting the need for effective biomarkers. Karyopherin alpha 2 (KPNA2), a nuclear transport protein, facilitates the expression of oncogenic transcription factors (e.g. c-Myc). However, the clinical and functional implications of KPNA2 expression in pathological T4 (pT4) CRC in relation to the status of p53, a tumour suppressor, and c-Myc regulation remain unclear. Methods KPNA2 and p53 expression in 78 surgically resected pT4 CRC samples was assessed using immunohistochemistry. Functional analyses were conducted using short hairpin RNA-mediated KPNA2 knockdown in p53-mutant, wild-type p53 and p53-null CRC cell lines. Results High KPNA2 expression significantly associated with aggressive tumour characteristics and poor prognosis, particularly in the wild-type p53 patient subgroup. Clinically, elevated KPNA2 levels correlated with increased distant metastasis rates and reduced disease-free survival, especially in patients with wild-type p53 receiving adjuvant chemotherapy. KPNA2 suppression reduced cell proliferation, inhibited xenograft tumour growth and selectively enhanced 5-FU and oxaliplatin sensitivity in wild-type p53 CRC cells. KPNA2 knockdown impaired nuclear c-Myc transport and induced p53-dependent p21 expression; however, these effects were not observed in p53-mutant or p53-null CRC. Conclusions KPNA2 expression may serve as an important prognostic biomarker and therapeutic target in patients with locally advanced wild-type p53 CRC.
- Open Access
- 19 February 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (4) , 1975
Smaller Oxygen Nanobubbles More Effectively Suppress Colitis and Colon Carcinogenesis than Larger Oxygen Nanobubbles
Oxygen nanobubble (NBO2) water is reportedly a promising therapeutic and radiosensitizing agent against solid cancers. However, the significance of nanobubble size in inflammation-associated colorectal carcinogenesis in vivo remains elusive. We investigated whether small NBO2 water exerts stronger preventive effects against colitis and colorectal carcinogenesis in an azoxymethane/dextran sulfate sodium–induced mouse model of colitis-associated cancer. Differences in particle size between the small and large NBO2 water samples were confirmed by atomic force microscopy. The mice received drinking water containing either small or large sized NBO2 throughout the experiment. Small NBO2 water significantly reduced disease activity index scores, histopathological colitis scores, colonic shortening, CD68-positive inflammatory macrophage density, and tumor numbers. However, body weight, water intake, food intake, and spleen weight were unaffected. Immunohistochemistry revealed that small NBO2 water reduced the percentage of Ki-67-positive tumor cells and the proportions of hypoxia-inducible factor-1α–positive epithelial and stromal cells, whereas no significant differences were observed in CD8- or forkhead box P3-positive cells. We conclude that nanometer-sized oxygen bubbles prevent inflammation-associated colorectal carcinogenesis, and that particle size is a critical determinant of biological effects. Small amounts of NBO2 water may help control colitis and tumor development by alleviating hypoxia in the tumor microenvironment.
- 19 February 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (4) , 1975
Open AccessSmaller Oxygen Nanobubbles More Effectively Suppress Colitis and Colon Carcinogenesis than Larger Oxygen Nanobubbles
Oxygen nanobubble (NBO2) water is reportedly a promising therapeutic and radiosensitizing agent against solid cancers. However, the significance of nanobubble size in inflammation-associated colorectal carcinogenesis in vivo remains elusive. We investigated whether small NBO2 water exerts stronger preventive effects against colitis and colorectal carcinogenesis in an azoxymethane/dextran sulfate sodium–induced mouse model of colitis-associated cancer. Differences in particle size between the small and large NBO2 water samples were confirmed by atomic force microscopy. The mice received drinking water containing either small or large sized NBO2 throughout the experiment. Small NBO2 water significantly reduced disease activity index scores, histopathological colitis scores, colonic shortening, CD68-positive inflammatory macrophage density, and tumor numbers. However, body weight, water intake, food intake, and spleen weight were unaffected. Immunohistochemistry revealed that small NBO2 water reduced the percentage of Ki-67-positive tumor cells and the proportions of hypoxia-inducible factor-1α–positive epithelial and stromal cells, whereas no significant differences were observed in CD8- or forkhead box P3-positive cells. We conclude that nanometer-sized oxygen bubbles prevent inflammation-associated colorectal carcinogenesis, and that particle size is a critical determinant of biological effects. Small amounts of NBO2 water may help control colitis and tumor development by alleviating hypoxia in the tumor microenvironment.
- Open Access
- 9 January 2026
- Published by Wiley in Annals of Gastroenterological Surgery
- Vol. 10 (4) , 928-959
Annual Report of the 2022 National Clinical Database: Decade‐Long Trends and Current Status of Gastroenterological Surgery in Japan
Aim: The National Clinical Database (NCD) of Japan is the largest nationwide registry, covering over 95% of surgeries in the country. This 2022 annual report summarizes the short‐term outcomes of gastroenterological surgeries and discusses trends and insights over the past decade. Methods: We analyzed the NCD data for gastroenterological surgeries performed between 2013 and 2022. The number of surgeries, patient demographics, surgical approaches, postoperative outcomes, and the involvement of board‐certified surgeons and anesthesiologists were examined. Results: A total of 591 221 surgeries were recorded in 2022. Compared to 2021, the overall surgical volume remained stable, with a continued increase in minimally invasive procedures. Patient aging continued across all organ categories, with a rise in the proportion of patients aged ≥ 80 years. Board‐certified surgeon participation remained high in complex procedures, while emergency surgeries were associated with higher morbidity and mortality. Operative mortality continued to decrease, particularly in pancreatic and hepatic surgeries. Conclusion: The 2022 NCD data provide a comprehensive overview of the current status and evolving trends in gastroenterological surgery in Japan. Continued efforts toward data‐driven quality improvement and surgical education remain essential.
- 9 January 2026
- Published by Wiley in Annals of Gastroenterological Surgery
- Vol. 10 (4) , 928-959
Open AccessAnnual Report of the 2022 National Clinical Database: Decade‐Long Trends and Current Status of Gastroenterological Surgery in Japan
Aim: The National Clinical Database (NCD) of Japan is the largest nationwide registry, covering over 95% of surgeries in the country. This 2022 annual report summarizes the short‐term outcomes of gastroenterological surgeries and discusses trends and insights over the past decade. Methods: We analyzed the NCD data for gastroenterological surgeries performed between 2013 and 2022. The number of surgeries, patient demographics, surgical approaches, postoperative outcomes, and the involvement of board‐certified surgeons and anesthesiologists were examined. Results: A total of 591 221 surgeries were recorded in 2022. Compared to 2021, the overall surgical volume remained stable, with a continued increase in minimally invasive procedures. Patient aging continued across all organ categories, with a rise in the proportion of patients aged ≥ 80 years. Board‐certified surgeon participation remained high in complex procedures, while emergency surgeries were associated with higher morbidity and mortality. Operative mortality continued to decrease, particularly in pancreatic and hepatic surgeries. Conclusion: The 2022 NCD data provide a comprehensive overview of the current status and evolving trends in gastroenterological surgery in Japan. Continued efforts toward data‐driven quality improvement and surgical education remain essential.
- Open Access
Therapy-Induced Neutropenia and Poor Prognosis in Patients with Locally Advanced Esophageal Cancer Who Underwent Concurrent Chemoradiotherapy with Docetaxel, Cisplatin, and 5-Fluorouracil
Background: The prognostic impact of therapy-induced neutropenia in patients receiving definitive chemoradiotherapy for locally advanced thoracic esophageal cancer (EC) remains inadequately characterized. This study aimed to evaluate the association between grade 3–4 neutropenia and survival outcomes following docetaxel–cisplatin–5-fluorouracil (DCF) combined with radiotherapy (DCF-RT). Methods: Fifty patients with locally advanced thoracic EC were included in this study. Chemotherapy consisted of intravenous docetaxel at 50 mg/m2 (day 1), CDDP at 60 mg/m2 (day 1), and 5-FU at 600 mg/m2 (days 1 to 4), administered every four weeks for two cycles in combination with radiotherapy (60 Gy in 30 fractions). Toxicities were assessed using the Common Terminology Criteria for Adverse Events. Overall survival (OS), progression-free survival (PFS), locoregional control and distant metastasis-free survival were compared by neutropenia grade. Results: Grade 3–4 neutropenia occurred in 80% (95% CI: 66.3–90.0) of patients. The OS rate was significantly lower in those with grade 3–4 neutropenia than in those with grade 0–2 (p = 0.006). Multivariate analysis identified grade 3–4 neutropenia (HR 3.77; 95% CI: 1.35–10.56) and complete response (CR) (HR 0.47; 95% CI: 0.25–0.87) as independent prognostic factors for OS among patients who received definitive CRT. Among 38 patients with recurrence or residual disease, those with grade 3–4 neutropenia exhibited significantly greater reductions in lymphocyte counts at recurrence versus pretreatment (p = 0.012) compared with those with grade 0–2 neutropenia. Conclusions: Therapy-induced neutropenia is an independent prognostic factor for OS in locally advanced thoracic EC patients undergoing definitive DCF-RT. It may also serve as a predictor of insufficient lymphocyte recovery following chemoradiation.
Open AccessTherapy-Induced Neutropenia and Poor Prognosis in Patients with Locally Advanced Esophageal Cancer Who Underwent Concurrent Chemoradiotherapy with Docetaxel, Cisplatin, and 5-Fluorouracil
Background: The prognostic impact of therapy-induced neutropenia in patients receiving definitive chemoradiotherapy for locally advanced thoracic esophageal cancer (EC) remains inadequately characterized. This study aimed to evaluate the association between grade 3–4 neutropenia and survival outcomes following docetaxel–cisplatin–5-fluorouracil (DCF) combined with radiotherapy (DCF-RT). Methods: Fifty patients with locally advanced thoracic EC were included in this study. Chemotherapy consisted of intravenous docetaxel at 50 mg/m2 (day 1), CDDP at 60 mg/m2 (day 1), and 5-FU at 600 mg/m2 (days 1 to 4), administered every four weeks for two cycles in combination with radiotherapy (60 Gy in 30 fractions). Toxicities were assessed using the Common Terminology Criteria for Adverse Events. Overall survival (OS), progression-free survival (PFS), locoregional control and distant metastasis-free survival were compared by neutropenia grade. Results: Grade 3–4 neutropenia occurred in 80% (95% CI: 66.3–90.0) of patients. The OS rate was significantly lower in those with grade 3–4 neutropenia than in those with grade 0–2 (p = 0.006). Multivariate analysis identified grade 3–4 neutropenia (HR 3.77; 95% CI: 1.35–10.56) and complete response (CR) (HR 0.47; 95% CI: 0.25–0.87) as independent prognostic factors for OS among patients who received definitive CRT. Among 38 patients with recurrence or residual disease, those with grade 3–4 neutropenia exhibited significantly greater reductions in lymphocyte counts at recurrence versus pretreatment (p = 0.012) compared with those with grade 0–2 neutropenia. Conclusions: Therapy-induced neutropenia is an independent prognostic factor for OS in locally advanced thoracic EC patients undergoing definitive DCF-RT. It may also serve as a predictor of insufficient lymphocyte recovery following chemoradiation.
- Open Access
- 28 December 2025
- Published by Wiley in Annals of Gastroenterological Surgery
- Vol. 10 (3) , 893-903
Psoas Muscle Volume as a Predictor of Postoperative Complications in Patients Undergoing Emergency Surgery for Strangulated Small Bowel Obstruction: A Retrospective Single‐Center Study
Aim: This study evaluated preoperative psoas muscle volume, measured by plain computed tomography, as an independent predictor of short‐term postoperative outcomes in patients undergoing surgery for strangulated small bowel obstruction, and examined the impact of postoperative complications. Methods: This retrospective, single‐center study included 107 patients who underwent emergency strangulated small bowel obstruction surgery between January 2013 and December 2024. Demographics, clinical and surgical variables, laboratory values, and outcomes were reviewed. Psoas muscle volume, subcutaneous fat area, visceral fat area, and psoas muscle index were measured on preoperative computed tomography. Results: Receiver operating characteristic analysis identified 45.4 as the optimal psoas muscle volume cutoff, dividing patients into high (≥ 45.4) and low (< 45.4) groups. The low psoas muscle volume group was older, with lower BMI, nutritional indices, and serum albumin. Complications occurred more frequently in the low psoas muscle volume group, most commonly pneumonia. Severe complications (Clavien–Dindo ≥ III) were confined to patients aged ≥ 75 years, predominantly with low psoas muscle volume. Multivariate analysis identified advanced age and low psoas muscle volume as independent risk factors. Complications were associated with delayed bowel recovery, longer hospitalization, and reduced home‐discharge rates. Low psoas muscle volume independently predicted cardiopulmonary and systemic complications but not infectious or gastrointestinal complications. Conclusion: Advanced age and low psoas muscle volume independently predicted postoperative complications. Low psoas muscle volume was particularly linked to cardiopulmonary and systemic events, highlighting the need for preoperative risk stratification and early multidisciplinary management in older adults having strangulated small bowel obstruction with reduced muscle mass. Trial Registration: Not applicable
- 28 December 2025
- Published by Wiley in Annals of Gastroenterological Surgery
- Vol. 10 (3) , 893-903
Open AccessPsoas Muscle Volume as a Predictor of Postoperative Complications in Patients Undergoing Emergency Surgery for Strangulated Small Bowel Obstruction: A Retrospective Single‐Center Study
Aim: This study evaluated preoperative psoas muscle volume, measured by plain computed tomography, as an independent predictor of short‐term postoperative outcomes in patients undergoing surgery for strangulated small bowel obstruction, and examined the impact of postoperative complications. Methods: This retrospective, single‐center study included 107 patients who underwent emergency strangulated small bowel obstruction surgery between January 2013 and December 2024. Demographics, clinical and surgical variables, laboratory values, and outcomes were reviewed. Psoas muscle volume, subcutaneous fat area, visceral fat area, and psoas muscle index were measured on preoperative computed tomography. Results: Receiver operating characteristic analysis identified 45.4 as the optimal psoas muscle volume cutoff, dividing patients into high (≥ 45.4) and low (< 45.4) groups. The low psoas muscle volume group was older, with lower BMI, nutritional indices, and serum albumin. Complications occurred more frequently in the low psoas muscle volume group, most commonly pneumonia. Severe complications (Clavien–Dindo ≥ III) were confined to patients aged ≥ 75 years, predominantly with low psoas muscle volume. Multivariate analysis identified advanced age and low psoas muscle volume as independent risk factors. Complications were associated with delayed bowel recovery, longer hospitalization, and reduced home‐discharge rates. Low psoas muscle volume independently predicted cardiopulmonary and systemic complications but not infectious or gastrointestinal complications. Conclusion: Advanced age and low psoas muscle volume independently predicted postoperative complications. Low psoas muscle volume was particularly linked to cardiopulmonary and systemic events, highlighting the need for preoperative risk stratification and early multidisciplinary management in older adults having strangulated small bowel obstruction with reduced muscle mass. Trial Registration: Not applicable
- Open Access
- 25 December 2025
- Published by Elsevier in Advances in Radiation Oncology
- Vol. 11 (3) , 101987
Esophageal Cancer Cells Exhibit Heterogeneity in DNA Double-Strand Break Repair and G2/M Checkpoint Arrest Associated With Cell Viability After Ionizing Radiation
- 25 December 2025
- Published by Elsevier in Advances in Radiation Oncology
- Vol. 11 (3) , 101987
Open AccessEsophageal Cancer Cells Exhibit Heterogeneity in DNA Double-Strand Break Repair and G2/M Checkpoint Arrest Associated With Cell Viability After Ionizing Radiation
- Open Access
- 2 December 2025
- Published by Wiley in Annals of Gastroenterological Surgery
- Vol. 10 (3) , 710-721
Mature Tertiary Lymphoid Structures Indicate Good Chemotherapy Response and Prognosis in Advanced Colorectal Cancer
Background: Tertiary lymphoid structures (TLS), clusters of immune cells including B and T cells, are involved in anti‐tumor immunity and correlate with a favorable prognosis in several malignancies, but their association with systemic chemotherapy is unknown. We investigated the role of TLS as a biomarker for predicting chemotherapy efficacy in advanced colorectal cancer (CRC). Methods: We analyzed 78 CRC cases with metastatic or recurrent lesions, in which untreated resected primary tumors were available before chemotherapy. TLS maturity, defined by the presence of CD23 + B cells in germinal centers, was assessed by immunohistochemistry and evaluated in relation to clinicopathological features, treatment response, tumor‐infiltrating lymphocytes, and prognosis. In 11 cases with resected metastatic lesions, tumor‐infiltrating lymphocytes were analyzed to explore the relationship between TLS maturity in primary tumors and immune status at distant sites. Results: Mature TLS‐negative groups had poorer chemotherapy sensitivity, progression‐free survival, and overall survival. Multivariate analysis confirmed TLS maturity as an independent predictor of both therapeutic response and survival outcomes in this cohort. Mature TLS was associated with higher CD3 + and CD8 + T‐cell infiltration in both primary and metastatic tumors. Conclusion: Mature TLS may contribute to favorable chemotherapeutic efficacy through immune activity. TLS maturity in primary tumors may represent a novel biomarker for predicting systemic chemotherapy response and immune status across primary and metastatic sites in advanced CRC.
- 2 December 2025
- Published by Wiley in Annals of Gastroenterological Surgery
- Vol. 10 (3) , 710-721
Open AccessMature Tertiary Lymphoid Structures Indicate Good Chemotherapy Response and Prognosis in Advanced Colorectal Cancer
Background: Tertiary lymphoid structures (TLS), clusters of immune cells including B and T cells, are involved in anti‐tumor immunity and correlate with a favorable prognosis in several malignancies, but their association with systemic chemotherapy is unknown. We investigated the role of TLS as a biomarker for predicting chemotherapy efficacy in advanced colorectal cancer (CRC). Methods: We analyzed 78 CRC cases with metastatic or recurrent lesions, in which untreated resected primary tumors were available before chemotherapy. TLS maturity, defined by the presence of CD23 + B cells in germinal centers, was assessed by immunohistochemistry and evaluated in relation to clinicopathological features, treatment response, tumor‐infiltrating lymphocytes, and prognosis. In 11 cases with resected metastatic lesions, tumor‐infiltrating lymphocytes were analyzed to explore the relationship between TLS maturity in primary tumors and immune status at distant sites. Results: Mature TLS‐negative groups had poorer chemotherapy sensitivity, progression‐free survival, and overall survival. Multivariate analysis confirmed TLS maturity as an independent predictor of both therapeutic response and survival outcomes in this cohort. Mature TLS was associated with higher CD3 + and CD8 + T‐cell infiltration in both primary and metastatic tumors. Conclusion: Mature TLS may contribute to favorable chemotherapeutic efficacy through immune activity. TLS maturity in primary tumors may represent a novel biomarker for predicting systemic chemotherapy response and immune status across primary and metastatic sites in advanced CRC.
- Open Access
- 17 October 2025
- Published by Springer Nature in Surgery Today
- Vol. 55 (12) , 1782
Correction: Surgical treatment strategy for elderly patients with esophageal cancer in the new era: a narrative review
- 17 October 2025
- Published by Springer Nature in Surgery Today
- Vol. 55 (12) , 1782
Open AccessCorrection: Surgical treatment strategy for elderly patients with esophageal cancer in the new era: a narrative review